SAMSRITA LABS LIMITED (SAMSRITA.BO)
INR 22.97
(4.98%)
INR 22.97
(4.98%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.49 Million INR | 84.87% |
| 2022 | -9.89 Million INR | -144.93% |
| 2021 | -4.04 Million INR | 55.83% |
| 2020 | -9.14 Million INR | 58.31% |
| 2019 | -21.94 Million INR | 10.76% |
| 2018 | -24.59 Million INR | -116.4% |
| 2017 | -11.36 Million INR | -90.06% |
| 2016 | -5.97 Million INR | -1681.72% |
| 2015 | -335.56 Thousand INR | 50.24% |
| 2014 | -674.33 Thousand INR | -1806.94% |
| 2013 | -35.36 Thousand INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -276 Thousand INR | 58.71% |
| 2023 Q4 | -668.38 Thousand INR | -46.9% |
| 2023 Q1 | -861 Thousand INR | 89.26% |
| 2023 Q2 | -485 Thousand INR | 43.67% |
| 2023 Q3 | -455 Thousand INR | 6.19% |
| 2023 FY | -2.48 Million INR | 74.9% |
| 2022 Q1 | -883 Thousand INR | 57.07% |
| 2022 Q4 | -8.01 Million INR | -1349.73% |
| 2022 Q2 | -449 Thousand INR | 49.15% |
| 2022 FY | -9.89 Million INR | -144.93% |
| 2022 Q3 | -553 Thousand INR | -23.16% |
| 2021 Q1 | -836 Thousand INR | 0.0% |
| 2021 FY | -4.04 Million INR | 55.83% |
| 2021 Q4 | -2.05 Million INR | -252.23% |
| 2021 Q3 | -584 Thousand INR | 9.18% |
| 2021 Q2 | -643 Thousand INR | 23.09% |
| 2020 FY | -9.14 Million INR | 58.31% |
| 2019 FY | -21.94 Million INR | 10.76% |
| 2018 FY | -24.59 Million INR | -116.4% |
| 2017 FY | -11.36 Million INR | -90.06% |
| 2016 FY | -5.97 Million INR | -1681.72% |
| 2015 FY | -335.56 Thousand INR | 50.24% |
| 2014 FY | -674.33 Thousand INR | -1806.94% |
| 2013 FY | -35.36 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 9.28 Million INR | 116.13% |
| Biocon Limited | 50.83 Billion INR | 100.003% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 100.044% |
| Concord Biotech Limited | 6.26 Billion INR | 100.024% |
| Dishman Carbogen Amcis Limited | -13.9 Million INR | 89.227% |
| FERMENTA BIOTECH LIMITED | 1.06 Billion INR | 100.14% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.27 Million INR | 217.373% |
| Lyka Labs Limited | 29.13 Million INR | 105.14% |
| Panacea Biotec Limited | -309.7 Million INR | 99.517% |
| Servoteach Industries Limited | -785.00 INR | -190649.045% |
| SMS Lifesciences India Limited | 359.47 Million INR | 100.417% |
| Supriya Lifescience Limited | 1.57 Billion INR | 100.095% |
| Syngene International Limited | 14.02 Billion INR | 100.011% |
| TAKE Solutions Limited | -213.49 Million INR | 99.299% |
| Titan Biotech Limited | 315.89 Million INR | 100.474% |
| Transgene Biotek Limited | -7.08 Million INR | 78.877% |
| Vanta Bioscience Limited | -31.83 Million INR | 95.297% |